Your browser doesn't support javascript.
loading
The Clinical Efficacy and Safety of Four-Weekly Docetaxel as First-Line Therapy in Elderly Lung Cancer Patients with Squamous Cell Carcinoma.
Choi, Jong Hyun; Choi, Juwhan; Chung, Sang Mi; Oh, Jee Youn; Lee, Young Seok; Min, Kyung Hoon; Hur, Gyu Young; Shim, Jae Jeong; Kang, Kyung Ho; Lee, Hyun Kyung; Lee, Sung Yong.
Afiliação
  • Choi JH; Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
  • Choi J; Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
  • Chung SM; Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
  • Oh JY; Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
  • Lee YS; Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
  • Min KH; Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
  • Hur GY; Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
  • Shim JJ; Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
  • Kang KH; Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
  • Lee HK; Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea.
  • Lee SY; Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea. syl0801@korea.ac.kr.
Tuberc Respir Dis (Seoul) ; 82(3): 211-216, 2019 Jul.
Article em En | MEDLINE | ID: mdl-30841020

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article